Evotec SE (EVOTF) Operating Margin (2020 - 2025)
Evotec SE's (EVOTF) quarterly Operating Margin came in at 14.92% in Q4 2025, up 1239.0% year-on-year from 1.11% in Q4 2024, and up 154.96% quarter-over-quarter from 27.15% in Q3 2025.
Evotec SE (EVOTF) Operating Margin (2020 - 2025) Analysis & Trends
Evotec SE has disclosed Operating Margin across 6 years of filings, most recently posting 14.92% for Q4 2025.
- Operating Margin for Q4 2025 came in at 14.92%, up 1239.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 3.36% (up 44.0% YoY), and the FY2025 annual result was 0.01%, up 1787.0% from the prior year.
- Operating Margin came in at 14.92% for Q4 2025 at Evotec SE, up from 27.15% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 14.92% in Q4 2025 to a low of 27.15% in Q3 2025.
- The 5-year median for Operating Margin is 1.11% (2021), against an average of 1.29%.
- Across the five-year window, Operating Margin sank 2054 bps in 2024 and jumped 1239 bps in 2025, its largest moves.
- Evotec SE's Operating Margin stood at 6.05% in 2021, then slumped by 155 bps to 3.3% in 2022, then tumbled by 88 bps to 6.2% in 2023, then jumped by 141 bps to 2.53% in 2024, then soared by 489 bps to 14.92% in 2025.
- The last three Operating Margin figures came in at 14.92% (Q4 2025), 27.15% (Q3 2025), and 2.53% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Evotec SE | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.92% |
| Sep 30, 2025 | -27.15% |
| Dec 31, 2024 | 2.53% |
| Sep 30, 2024 | -14.33% |
| Dec 31, 2023 | -6.20% |
| Sep 30, 2023 | 6.21% |
| Jun 30, 2023 | -21.31% |
| Dec 31, 2022 | -3.30% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | -2.19% |
| Mar 31, 2022 | 0.28% |
| Dec 31, 2021 | 6.05% |
| Sep 30, 2021 | 11.11% |
| Jun 30, 2021 | 1.11% |
| Mar 31, 2021 | 5.09% |
| Dec 31, 2020 | 9.69% |